TAI •
Healthcare •
Biotechnology •
Quote as of 07/24/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTAI
Market Capitalization16,143 mln
Float36.38 mln
EPS
0.32
Overpriced
P / E
773
Bubble territory
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.58
Likely reliable
Relative Strength
21
/ 100
Significantly lagging
Debt / Equity
0.04
Debt-free
Business Description
Founded in 1998 and based in New Taipei City, Taiwan, TCM Biotech International Corp. develops treatments and therapies centered on liver disease research. The company also manufactures and distributes a range of medical devices and pharmaceutical products, covering areas such as joint care, cancer treatment, blood pressure, diabetes, and respiratory support. In addition, TCM Biotech operates diagnostic platforms designed to assess breast cancer risk and monitor liver cancer following surgery.
